FOCL · Edap Tms SA · Metrics
$4.12
-0.11 (-2.60%)
At close · Oct 27
Return incl. dividend (before tax)
Q4 2025 earnings call transcript
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 7, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$194.53M
Shares
47.22M
Volume · Oct 27
10.2K
Avg daily vol (3M)
111.59K
FOCL metrics
43 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$4.12
Market cap
$194.53M
Price action
20 metricsPrice change (1W)
-1.9%
Price change (30D)
-9.1%
Price change (3M)
-32.0%
Price change (6M)
+25.6%
Price change (YTD)
+25.2%
Price change (1Y)
+76.1%
Trailing year
Price change (5Y)
-32.6%
52-week high
$6.34
52-week low
$1.81
Change from 52-week high
-35.0%
Change from 52-week low
+127.6%
Annualized volatility
75.1%
Annualized volatility (3M)
62.6%
Beta
0.8
RSI (14D)
45.1
Price vs SMA 50
-3.2%
Price vs SMA 200
-6.5%
Avg volume (3M)
111,586
Relative volume
0.1
Average dollar volume
$513,261
Company
3 metricsSector
Healthcare
Industry
Medical Distribution
Shares outstanding
47.22M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-05
Last earnings
2026-08-13
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
38
13F filer change QoQ
-1
Institutional ownership
33.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
24.5%
Private-fund adviser ownership
5.0%
Active holders' share change QoQ
+2.0%
Holder tenure
20.8
Price vs estimated holder cost
-25.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.7%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
$551,000
Insider-sentiment score
94 / 100
Risk flags
1 metricsGoing concern
—